Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
Public ClinicalTrials.gov record NCT02422940. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Extension Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine Extended-Release Tablets. for the Treatment of Chronic Post-Ischemic Stroke Walking Deficits .
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an extension study to evaluate the long-term safety, tolerability, and efficacy of two dose strengths of dalfampridine-ER.
Study identification
- NCT ID
- NCT02422940
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 294 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2015 (Type not available)
- Primary completion
- Jan 2017 (Actual)
- Completion
- Jan 2017 (Actual)
- Last update posted
- Jan 22, 2019
2015 – 2017
United States locations
- U.S. sites
- 62
- U.S. states
- 27
- U.S. cities
- 57
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Acorda Site #117 | Gilbert | Arizona | 85234 | — |
| Acorda Site #109 | Berkeley | California | 94705 | — |
| Acorda Site #170 | Carlsbad | California | 92011 | — |
| Acorda Site #138 | Long Beach | California | 90806 | — |
| Acorda Site #105 | Newport Beach | California | 92663 | — |
| Acorda Site #142 | Pasadena | California | 91105 | — |
| Acorda Site #153 | Sacramento | California | 95823 | — |
| Acorda Site #151 | San Diego | California | 921018466 | — |
| Acorda Site #163 | San Diego | California | 92123 | — |
| Acorda Site #124 | Colorado Springs | Colorado | 80907 | — |
| Acorda Site #110 | Danbury | Connecticut | 06810 | — |
| Acorda Site #149 | Fairfield | Connecticut | 06824 | — |
| Acorda Site #130 | Stamford | Connecticut | 06905 | — |
| Acorda Site #115 | Atlantis | Florida | 33462 | — |
| Acorda Site #119 | Deerfield Beach | Florida | 33441 | — |
| Acorda Site #147 | Gainesville | Florida | 326100236 | — |
| Acorda Site #128 | Hialeah | Florida | 33012 | — |
| Acorda Site #184 | Jacksonville | Florida | 32277 | — |
| Acorda Site #103 | Miami | Florida | 33142 | — |
| Acorda Site #133 | Miami | Florida | 33175 | — |
| Acorda Site #161 | Naples | Florida | 34102 | — |
| Acorda Site #106 | Tampa | Florida | 33606 | — |
| Acorda Site #181 | Honolulu | Hawaii | 96817 | — |
| Acorda Site #171 | Chicago | Illinois | 60611 | — |
| Acorda Site #148 | Avon | Indiana | 46123 | — |
| Acorda Site #188 | Fort Wayne | Indiana | 46804 | — |
| Acorda Site #156 | Franklin | Indiana | 46131 | — |
| Acorda Site #146 | Lexington | Kentucky | 40513 | — |
| Acorda Site #150 | New Orleans | Louisiana | 70121 | — |
| Acorda Site #175 | Fulton | Maryland | 20759 | — |
| Acorda Site #136 | Boston | Massachusetts | 02114 | — |
| Acorda Site #121 | Boston | Massachusetts | 02118 | — |
| Acorda Site #123 | East Lansing | Michigan | 48824 | — |
| Acorda Site #164 | Farmington Hills | Michigan | 48334 | — |
| Acorda Site #159 | Grand Rapids | Michigan | 49503 | — |
| Acorda Site #101 | Kansas City | Missouri | 64132 | — |
| Acorda Site #111 | Great Falls | Montana | 59405 | — |
| Acorda Site #140 | Reno | Nevada | 89502 | — |
| Acorda Site #131 | New Brunswick | New Jersey | 08901 | — |
| Acorda Site #177 | Stratford | New Jersey | 08084 | — |
| Acorda Site #172 | New York | New York | 10029 | — |
| Acorda Site #179 | Patchogue | New York | 11772 | — |
| Acorda Site #114 | White Plains | New York | 10605 | — |
| Acorda Site #166 | Chapel Hill | North Carolina | 27599 | — |
| Acorda Site #167 | Durham | North Carolina | 27710 | — |
| Acorda Site #162 | Mooresville | North Carolina | 28117 | — |
| Acorda Site #154 | Raleigh | North Carolina | 276076010 | — |
| Acorda Site #132 | Winston-Salem | North Carolina | 27103 | — |
| Acorda Site #137 | Columbus | Ohio | 43210 | — |
| Acorda Site #116 | Dayton | Ohio | 45417 | — |
| Acorda Site #152 | Corvallis | Oregon | 97330 | — |
| Acorda Site #168 | Portland | Oregon | 97225 | — |
| Acorda Site #126 | Portland | Oregon | 97239 | — |
| Acorda Site #122 | Philadelphia | Pennsylvania | 19104 | — |
| Acorda Site #144 | Providence | Rhode Island | 02903 | — |
| Acorda Site #157 | Memphis | Tennessee | 38163 | — |
| Acorda Site #113 | Dallas | Texas | 75214 | — |
| Acorda Site #165 | Dallas | Texas | 75246 | — |
| Acorda Site #108 | Houston | Texas | 77030 | — |
| Acorda Site #182 | Falls Church | Virginia | 22043 | — |
| Acorda Site #176 | Richmond | Virginia | 23298 | — |
| Acorda Site #107 | Spokane | Washington | 992021330 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02422940, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 22, 2019 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02422940 live on ClinicalTrials.gov.